AVID100 in Advanced Epithelial Carcinomas
Public ClinicalTrials.gov record NCT03094169. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1a/2a Dose Escalation Trial to Determine Safety, Tolerance, MTD, and Preliminary Antineoplastic Activity of AVID100, in Patients With Advanced or Metastatic Solid Tumors of Epithelial Origin
Study identification
- NCT ID
- NCT03094169
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Formation Biologics
- Industry
- Enrollment
- 49 participants
Conditions and interventions
Conditions
Interventions
- AVID100 IV Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2017
- Primary completion
- Nov 27, 2020
- Completion
- Jan 29, 2021
- Last update posted
- Jun 10, 2025
2017 – 2021
United States locations
- U.S. sites
- 10
- U.S. states
- 5
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yale | New Haven | Connecticut | 06511 | — |
| START Midwest | Grand Rapids | Michigan | 49503 | — |
| The Tisch Cancer Institute-Mt. Sinai | New York | New York | 10029 | — |
| Fox Chase | Philadelphia | Pennsylvania | 19111 | — |
| Texas Oncology Midtown | Austin | Texas | 78705 | — |
| Texas Oncology-Baylor -Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Texas Oncology McAllen | McAllen | Texas | 78503 | — |
| Texas Oncology NE San Antonio | San Antonio | Texas | 78217 | — |
| Texas Oncology Tyler | Tyler | Texas | 75702 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03094169, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 10, 2025 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03094169 live on ClinicalTrials.gov.